Julie Rosenthal, MD, MS, discusses the future direction of research into treating age-related macular degeneration.

Retinal diseases such as age-related macular degeneration (AMD) and diabetic retinopathy affect millions of people globally, often leading to vision loss with minimal straightforward treatment.

An emerging approach that uses aqueous chlorhexidine to prevent infections after intravitreal injections to deliver drugs into the eye is as effective as the long prevailing method that uses povidone ...

Continuous administration of ranibizumab with a port delivery system provides an alternative to frequent intravitreal injections for diabetic macular edema and helps delay progression of ...

Pakistan Tehreek-e-Insaf founder Imran Khan will receive his second eye injection on February 25, followed by a third in March, as part of a prescribed treatment plan under medical supervision, ...

People with a condition called wet age-related macular degeneration (AMD) often receive eye injections. These eye injections can help to improve vision and also stop the damage that causes vision to ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify [email protected] if there are concerns regarding accuracy of the transcription.